- Home
- DENN vs CDXS Comparison
DENN vs CDXS Comparison
Compare DENN & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DENN
- CDXS
- Stock Information
- Founded
- DENN 1953
- CDXS 2002
- Country
- DENN United States
- CDXS United States
- Employees
- DENN N/A
- CDXS N/A
- Industry
- DENN Restaurants
- CDXS Major Chemicals
- Sector
- DENN Consumer Discretionary
- CDXS Industrials
- Exchange
- DENN Nasdaq
- CDXS Nasdaq
- Market Cap
- DENN 203.4M
- CDXS 230.3M
- IPO Year
- DENN 1989
- CDXS 2010
- Fundamental
- Price
- DENN $3.82
- CDXS $2.49
- Analyst Decision
- DENN Strong Buy
- CDXS Buy
- Analyst Count
- DENN 6
- CDXS 2
- Target Price
- DENN $7.75
- CDXS $11.00
- AVG Volume (30 Days)
- DENN 1.5M
- CDXS 1.1M
- Earning Date
- DENN 04-29-2025
- CDXS 05-01-2025
- Dividend Yield
- DENN N/A
- CDXS N/A
- EPS Growth
- DENN 17.14
- CDXS N/A
- EPS
- DENN 0.41
- CDXS N/A
- Revenue
- DENN $452,334,000.00
- CDXS $59,345,000.00
- Revenue This Year
- DENN $5.81
- CDXS $12.62
- Revenue Next Year
- DENN $2.50
- CDXS $22.11
- P/E Ratio
- DENN $9.30
- CDXS N/A
- Revenue Growth
- DENN N/A
- CDXS N/A
- 52 Week Low
- DENN $3.61
- CDXS $2.42
- 52 Week High
- DENN $8.85
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- DENN 35.98
- CDXS 36.23
- Support Level
- DENN $3.61
- CDXS $2.43
- Resistance Level
- DENN $4.01
- CDXS $3.04
- Average True Range (ATR)
- DENN 0.17
- CDXS 0.21
- MACD
- DENN 0.05
- CDXS 0.04
- Stochastic Oscillator
- DENN 42.00
- CDXS 8.78
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.